Showing results (71-80 of 134) with videos related to
Sort By:
Pageof 14
Biochemical and Biophysical Research Communications|December 29, 1989
Highly specific inhibition of human immunodeficiency virus type 1 by a novel 6-substituted acyclouridine derivativeM Baba, H Tanaka, E De Clercq, et al.The Journal of Experimental Medicine|March 1, 1989
Replication of human immunodeficiency virus in monocytes. Granulocyte/macrophage colony-stimulating factor (GM-CSF) potentiates viral production yet enhances the antiviral effect mediated by 3'-azido-2'3'-dideoxythymidine (AZT) and other dideoxynucleoside congeners of thymidineC F Perno, R Yarchoan, D A Cooney, et al.Annals of Neurology|January 1, 1988
Long-term administration of 3'-azido-2',3'-dideoxythymidine to patients with AIDS-related neurological diseaseR Yarchoan, R V Thomas, J Grafman, et al.The Journal of Infectious Diseases|November 1, 1993
Inhibition of the protease of human immunodeficiency virus blocks replication and infectivity of the virus in chronically infected macrophagesC F Perno, A Bergamini, C D Pesce, et al.Proceedings of the National Academy of Sciences of the United States of America|May 15, 1992
2',5'-Bis-O-(tert-butyldimethylsilyl)-3'-spiro-5''-(4''-amino-1'',2''- oxathiole-2'',2'-dioxide)pyrimidine (TSAO) nucleoside analogues: highlyselective inhibitors of human immunodeficiency virus type 1 that are targeted at the viral reverse transcriptaseJ Balzarini, M J Pérez-Pérez, A San-Félix, et al.Antiviral Research|June 1, 1995
Evidence for antiviral activity of glutathione: in vitro inhibition of herpes simplex virus type 1 replicationA T Palamara, C F Perno, M R Ciriolo, et al.Molecular Pharmacology|February 1, 1990
Potent DNA chain termination activity and selective inhibition of human immunodeficiency virus reverse transcriptase by 2',3'-dideoxyuridine-5'-triphosphateZ Hao, D A Cooney, D Farquhar, et al.FEBS Letters|June 30, 1997
Conversion of 2',3'-dideoxyadenosine (ddA) and 2',3'-didehydro-2',3'-dideoxyadenosine (d4A) to their corresponding aryloxyphosphoramidate derivatives markedly potentiates their activity against human immunodeficiency virus and hepatitis B virusJ Balzarini, J Kruining, O Wedgwood, et al.Molecular Pharmacology|October 1, 1988
Factors determining the activity of 2',3'-dideoxynucleosides in suppressing human immunodeficiency virus in vitroZ Hao, D A Cooney, N R Hartman, et al.Journal of Biological Regulators and Homeostatic Agents|August 5, 1998
Clinical implications of HIV dynamics and drug resistance in macrophagesS Aquaro, R Caliò, E Balestra, et al.Pageof 14